A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study
- PMID: 11210070
- DOI: 10.1902/jop.2001.72.1.25
A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study
Abstract
Background: Previous studies have demonstrated that enamel matrix derivative (EMD) has the ability to improve clinical parameters when used to treat intraosseous defects. The purpose of the present study was to compare at 12 months postsurgery sites treated with open flap debridement (OFD) alone to those treated with OFD and EMD.
Methods: Twenty-three subjects with at least 2 intrabony defects were chosen. Fifty-three defects received EMD in conjunction with OFD. Thirty-one defects in these same 23 subjects were treated with OFD alone. Stents were fabricated to serve as fixed reference points. Re-entries were performed at least 1 year after initial surgery. Soft tissue measurements were recorded prior to initial surgery and prior to re-entry for gingival (GI) and plaque (PI) indices, probing depth (PD), gingival margin position, and clinical attachment level (CAL). Hard tissue measurements were recorded during the initial and re-entry surgery for level of crestal bone and depth of defect. Statistical analysis was conducted using the method of generalized estimating equations to determine changes in GI, PI, PD, CAL, fill of the osseous defect, and crestal resorption. Percent of defect fill was also calculated.
Results: In all categories, treatment with EMD (test) was superior to treatment without EMD (control). Average PI and GI were not significantly different either initially or prior to re-entry. The average PD reduction was 2.7 mm greater with EMD than controls. The average CAL gains were 1.5 mm greater, and the average fill of osseous defect 2.4 mm greater with EMD than controls. The average percent of defect fill after adjusting for crestal bone loss was more than 3 times greater for EMD versus control-treated sites (74% defect fill with EMD versus 23% defect fill for control sites).
Conclusions: This study indicates that treatment of periodontal intraosseous defects with EMD is clinically superior to treatment without EMD (open flap debridement) in every parameter evaluated. Re-entry data demonstrate that percent fill of osseous defects treated with EMD compares favorably with the treatment results utilizing bone grafts or membrane barriers, according to published literature.
Similar articles
-
Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.J Periodontol. 2002 Apr;73(4):433-40. doi: 10.1902/jop.2002.73.4.433. J Periodontol. 2002. PMID: 11990445 Clinical Trial.
-
Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.J Periodontol. 2004 Oct;75(10):1309-18. doi: 10.1902/jop.2004.75.10.1309. J Periodontol. 2004. PMID: 15562907 Clinical Trial.
-
A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.J Periodontol. 2002 Apr;73(4):423-32. doi: 10.1902/jop.2002.73.4.423. J Periodontol. 2002. PMID: 11990444 Clinical Trial.
-
An evaluation of bioactive glass in the treatment of periodontal defects: a meta-analysis of randomized controlled clinical trials.J Periodontol. 2012 Apr;83(4):453-64. doi: 10.1902/jop.2011.110347. Epub 2011 Aug 23. J Periodontol. 2012. PMID: 21861641 Review.
-
Predictability of clinical outcomes following regenerative therapy in intrabony defects.J Periodontol. 2008 Mar;79(3):387-93. doi: 10.1902/jop.2008.060521. J Periodontol. 2008. PMID: 18315419 Review.
Cited by
-
Effects of enamel matrix derivative on non-surgical management of peri-implant mucositis: a double-blind randomized clinical trial.Clin Oral Investig. 2017 Sep;21(7):2379-2388. doi: 10.1007/s00784-016-2033-7. Epub 2016 Dec 30. Clin Oral Investig. 2017. PMID: 28039545 Clinical Trial.
-
Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003875. doi: 10.1002/14651858.CD003875.pub3. Cochrane Database Syst Rev. 2009. PMID: 19821315 Free PMC article.
-
The Use of Biocompatible Membranes in Oral Surgery: The Past, Present & Future Directions. A Narrative Review.Membranes (Basel). 2022 Aug 29;12(9):841. doi: 10.3390/membranes12090841. Membranes (Basel). 2022. PMID: 36135860 Free PMC article. Review.
-
Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects.Clin Oral Investig. 2006 Sep;10(3):227-34. doi: 10.1007/s00784-006-0052-5. Epub 2006 May 16. Clin Oral Investig. 2006. PMID: 16703336 Clinical Trial.
-
Clinical Comparison of Autogenous Bone Graft with and without Plasma Rich in Growth Factors in the Treatment of Grade II Furcation Involvement of Mandibular Molars.J Dent Res Dent Clin Dent Prospects. 2013 Winter;7(1):22-9. doi: 10.5681/joddd.2013.004. Epub 2013 Feb 21. J Dent Res Dent Clin Dent Prospects. 2013. PMID: 23486928 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous